Literature DB >> 15560738

Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells.

Xiao Yun Shen1, Natalie Zacal, Gurmit Singh, Andrew J Rainbow.   

Abstract

Photodynamic therapy (PDT) is a novel cancer therapy inducing irreversible photodamage to tumor tissue via photosensitizer-mediated oxidative cytotoxicity. The cellular and molecular responses associated with PDT are only partially understood. We have reported previously the generation of several photosensitizer-specific PDT-resistant cell variants of HT29 human colon adenocarcinoma cells by selecting cells from sequential PDT treatment using different photosensitizers. In this report, we describe the use of messenger RNA (mRNA) differential display to identify genes that were differentially expressed in the parental HT29 cells compared with their resistant variants. In comparison with parental HT29 cells, mRNA expression was increased in the PDT-resistant cell variants for BNIP3, estrogen receptor-binding fragment-associated gene 9, Myh-1c, cytoplasmic dynein light chain 1, small membrane protein I and differential dependent protein. In contrast, expression in the PDT-resistant variants was downregulated for NNX3, human HepG2 3' region Mbol complementary DNA, glutamate dehydrogenase, hepatoma-derived growth factor and the mitochondrial genes coding for 16S ribosomal RNA (rRNA) and nicotinamide adenine dinucleotide (NADH) dehydrogenase subunit 4. The reduction for mitochondrial 16S rRNA in the PDT-resistant variants was confirmed by Northern blotting, and the elevated expression of the proapoptotic BNIP3 in the PDT-resistant variants was confirmed by Northern and Western blotting analysis. We also examined the expression of some additional apoptosis-regulating genes using Western blotting. We show an increased expression of Bcl-2 and heat shock protein 27 and a downregulation of Bax in the PDT-resistant variants. In addition, the mutant p53 levels in the parental HT29 cells were reduced substantially in the PDT-resistant variants. We suggest that the altered expression in several mitochondrial and apoptosis-regulating genes contributes to PDT resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15560738     DOI: 10.1562/2004-07-22-RA-242

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  7 in total

Review 1.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 2.  Which cell death modality wins the contest for photodynamic therapy of cancer?

Authors:  Maria Vedunova; Dmitri V Krysko; Tatiana Mishchenko; Irina Balalaeva; Anastasia Gorokhova
Journal:  Cell Death Dis       Date:  2022-05-13       Impact factor: 9.685

3.  Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation.

Authors:  Angela Sedlmaier; Nicolas Wernert; Rainer Gallitzendörfer; Mekky M Abouzied; Volkmar Gieselmann; Sebastian Franken
Journal:  BMC Cancer       Date:  2011-10-20       Impact factor: 4.430

Review 4.  Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain.

Authors:  Jose M Garcia-Heredia; Amancio Carnero
Journal:  Oncotarget       Date:  2015-12-08

5.  Cell death pathways in photodynamic therapy of cancer.

Authors:  Pawel Mroz; Anastasia Yaroslavsky; Gitika B Kharkwal; Michael R Hamblin
Journal:  Cancers (Basel)       Date:  2011       Impact factor: 6.639

Review 6.  Role of Bcl-2 Family Proteins in Photodynamic Therapy Mediated Cell Survival and Regulation.

Authors:  Eric Chekwube Aniogo; Blassan Plackal Adimuriyil George; Heidi Abrahamse
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

Review 7.  Molecular Effectors of Photodynamic Therapy-Mediated Resistance to Cancer Cells.

Authors:  Eric Chekwube Aniogo; Blassan P George; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.